CYTORI THERAPEUTICS, INC. 4/A
4/A · CYTORI THERAPEUTICS, INC. · Filed Mar 17, 2017
Insider Transaction Report
Form 4/AAmended
HARRIS JOHN DAVID
VP and GM Cell Therapy
Transactions
- Award
Incentive Stock Option (right to buy)
2017-03-08+31,100→ 31,100 totalExercise: $1.55Exp: 2027-03-08→ Common Stock (31,100 underlying)
Footnotes (1)
- [F1]Option shares shall vest and become exercisable over four (4) years in forty-eight consecutive monthly installments.